Invicro acquires Imanova to expand global imaging capabilities

Combined business delivers world-leading imaging capabilities to drive
improved decision-making from early drug discovery to late-phase clinical development

BOSTON, MA, September 12, 2017 – Invicro, LLC, a leading provider of imaging services and software for research and drug development, announced today the acquisition of UK-based Imanova. Invicro and Imanova will merge all activities to establish the world’s largest provider of translational imaging services and analytics from pre-clinical development through to late-phase clinical trials.